Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sildenafil therapy for severe early-onset intrauterine growth restriction
2013-005398-32Phase 3Completed
- Sponsor
- Liverpool Women's NHS Foundation Trust
- Start
- Feb 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial in intrauterine growth restriction (IUGR) comparing Sildenafil with Placebo (2 arms). Primary endpoint: Prolongation of pregnancy. Started Feb 2015; status: completed.
02
Drugs
sildenafil
03
Conditions
intrauterine growth restriction (IUGR)
Beyond the preview
Go deeper on 2013-005398-32.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-005398-32.